Vontobel Holding
PNT

Vontobel Holding’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Vontobel Holding’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-197,278
Closed -$1.44M – 1154
2022
Q4 		$1.44M Buy
+197,278
New +$1.46M 0.01% 489

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vontobel Holding's PNT Position: Q1 2023 in Review

Vontobel Holding sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q1 2023, closing a stake of 197,278 shares — an estimated $1.44M sold.

Vontobel Holding first reported a position in PNT in Q4 2022 and held it in 1 quarter. The position peaked at $1.44M in Q4 2022. 115 funds tracked by Wall St. Rank hold PNT as of Q1 2023.

  • Vontobel Holding reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Vontobel Holding sold 197,278 POINT Biopharma Global Inc. Common Stock shares in Q1 2023, an estimated $1.44M.
  • Vontobel Holding first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Vontobel Holding's POINT Biopharma Global Inc. Common Stock position peaked at $1.44M in Q4 2022.
  • 115 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q1 2023.

Based on Vontobel Holding's 13F filing for Q1 2023, filed 12 Apr 2023.